International Isotopes, Inc.
I-131 Sodium Iodide & Other Radiochemicals
International Isotopes Inc. (OTCQB: INIS) is proud to be the only FDA approved Sodium Iodide I-131 drug product manufactured in the United States…
EasyFill Automated Iodine Capsule System
This patented system allows for the hands-free preparation of iodine capsules, pairing perfectly with our iodine shielding and reducing radiation exposure.
Nuclear Medicine Calibration Standards
We are the North American distributor for LEA sources for control and calibration of equipment in the fields of radiation protection and metrology.
Cobalt Sealed Source Products
Our cobalt products are used by a broad array of companies for radiation treatment of cancer and vascular deformities of the brain. Cobalt sources are also used for container security examinations at our sea ports and borders.
Calibration Sources & Radioactive Standards
We are the North American distributor for LEA sources for control and calibration of equipment in the fields of radiation protection and metrology.
International Isotopes, Inc. Announces Financial Results for Third Quarter of 2024 and First Nine Months of 2024
- Company Revenues increased by over $1,000,000, or 34%, for the Third Quarter compared to the
prior year. - Theranostics Sales increased 42% compared the Third Quarter in the prior year.
- The Company reported a net profit of $150,000 for the Third Quarter, an improvement of $497,000
compared the Third Quarter in the prior year.
International Isotopes, Inc. Announces Joint Venture Agreement to Form PhanQual
INIS and Alpha Nuclides Sign Strategic Development and Distribution Agreements For China
International Isotopes, Inc. (INIS) and Alpha Nuclide Inc (AN) have entered into a Strategic Development and Distribution Agreement for the rights to manufacture and distribute INIS’s Theranostics and nuclear Medicine Products in mainland China.
INIS to Distribute Nuclear Shields B.V. Products
INIS is excited to announce that it has entered into a distribution agreement with Nuclear Shields B.V. to distribute their products in the United States.
Nuclear Shields designs and manufactures a wide rage of radiation shielding products for nuclear medicine, radiology, nuclear imaging and nuclear energy. Nuclear Shields is part of the Van Mullekom Group which was founded in The Netherlands in 1978. The company is privately owned and has factories and offices in the USA, Australia and The Netherlands.
Shahe Bagerdjian, President & CEO of INIS commented, “We are really excited to offer Nuclear Shields’ products to our customers. Their shielding solutions combine high quality engineering and eye-catch designs. Their complete portfolio of products are an excellent fit with our own diverse radioisotope offerings.”
International Isotopes, Inc. Announces Fiscal Results for Fiscal Year 2023
- Revenues Increased 10% in the Twelve Months Ended December 31, 2023 versus prior year.
- Revenue of $12.3 million in the Twelve Months Ended December 31, 2023 was the highest in
Company history. - Gross Profit Increased $1.1 million, or 17%, in the Twelve Months Ended December 31, 2023
versus prior year. - Approximately $0.6 million of Net Cash provided by operating activities in the Twelve Months
Ended December 31, 2023, an increase of over $2.0 million versus prior year.